1941 related articles for article (PubMed ID: 26706243)
21. Cancer stem cells (CSCs), cervical CSCs and targeted therapies.
Huang R; Rofstad EK
Oncotarget; 2017 May; 8(21):35351-35367. PubMed ID: 27343550
[TBL] [Abstract][Full Text] [Related]
22. Cancer Stem Cells in Prostate Cancer: Implications for Targeted Therapy.
Leão R; Domingos C; Figueiredo A; Hamilton R; Tabori U; Castelo-Branco P
Urol Int; 2017; 99(2):125-136. PubMed ID: 28142149
[TBL] [Abstract][Full Text] [Related]
23. Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways.
Kahlert UD; Mooney SM; Natsumeda M; Steiger HJ; Maciaczyk J
Int J Cancer; 2017 Jan; 140(1):10-22. PubMed ID: 27389307
[TBL] [Abstract][Full Text] [Related]
24. Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer.
Yun EJ; Zhou J; Lin CJ; Hernandez E; Fazli L; Gleave M; Hsieh JT
Clin Cancer Res; 2016 Feb; 22(3):670-9. PubMed ID: 26490309
[TBL] [Abstract][Full Text] [Related]
25. Nanomedicine-mediated cancer stem cell therapy.
Shen S; Xia JX; Wang J
Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
[TBL] [Abstract][Full Text] [Related]
26. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.
Liu J; Mao Z; Huang J; Xie S; Liu T; Mao Z
Biochem Biophys Res Commun; 2014 Feb; 444(4):670-5. PubMed ID: 24502949
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic potential of cancer stem cells.
Yang C; Jin K; Tong Y; Cho WC
Med Oncol; 2015 Jun; 32(6):619. PubMed ID: 25920610
[TBL] [Abstract][Full Text] [Related]
28. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
[TBL] [Abstract][Full Text] [Related]
29. Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance.
Mihanfar A; Aghazadeh Attari J; Mohebbi I; Majidinia M; Kaviani M; Yousefi M; Yousefi B
J Cell Physiol; 2019 Apr; 234(4):3238-3253. PubMed ID: 30317560
[TBL] [Abstract][Full Text] [Related]
30. Natural Compounds Targeting Cancer Stem Cells: A Promising Resource for Chemotherapy.
Das PK; Zahan T; Abdur Rakib M; Khanam JA; Pillai S; Islam F
Anticancer Agents Med Chem; 2019; 19(15):1796-1808. PubMed ID: 31272363
[TBL] [Abstract][Full Text] [Related]
31. CD10
Ffrench B; Gasch C; Hokamp K; Spillane C; Blackshields G; Mahgoub TM; Bates M; Kehoe L; Mooney A; Doyle R; Doyle B; O'Donnell D; Gleeson N; Hennessy BT; Stordal B; O'Riain C; Lambkin H; O'Toole S; O'Leary JJ; Gallagher MF
Cell Death Dis; 2017 Oct; 8(10):e3128. PubMed ID: 29048400
[TBL] [Abstract][Full Text] [Related]
32. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
[TBL] [Abstract][Full Text] [Related]
33. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy.
Wang Z; Ahmad A; Li Y; Azmi AS; Miele L; Sarkar FH
Anticancer Res; 2011 Apr; 31(4):1105-13. PubMed ID: 21508353
[TBL] [Abstract][Full Text] [Related]
34. Implications of cancer stem cells in the treatment of cancer.
Pan CX; Zhu W; Cheng L
Future Oncol; 2006 Dec; 2(6):723-31. PubMed ID: 17155899
[TBL] [Abstract][Full Text] [Related]
35. Biology and clinical implications of CD133(+) liver cancer stem cells.
Ma S
Exp Cell Res; 2013 Jan; 319(2):126-32. PubMed ID: 22999864
[TBL] [Abstract][Full Text] [Related]
36. Colon cancer: cancer stem cells markers, drug resistance and treatment.
Kozovska Z; Gabrisova V; Kucerova L
Biomed Pharmacother; 2014 Oct; 68(8):911-6. PubMed ID: 25458789
[TBL] [Abstract][Full Text] [Related]
37. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
Su P; Yang Y; Wang G; Chen X; Ju Y
Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
[TBL] [Abstract][Full Text] [Related]
38. Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer.
Sette G; Salvati V; Mottolese M; Visca P; Gallo E; Fecchi K; Pilozzi E; Duranti E; Policicchio E; Tartaglia M; Milella M; De Maria R; Eramo A
Cell Death Dis; 2015 Aug; 6(8):e1850. PubMed ID: 26247735
[TBL] [Abstract][Full Text] [Related]
39. A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms.
Cojoc M; Mäbert K; Muders MH; Dubrovska A
Semin Cancer Biol; 2015 Apr; 31():16-27. PubMed ID: 24956577
[TBL] [Abstract][Full Text] [Related]
40. Lung cancer stem cells: tumor biology and clinical implications.
Nurwidya F; Murakami A; Takahashi F; Takahashi K
Asia Pac J Clin Oncol; 2012 Sep; 8(3):217-22. PubMed ID: 22897822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
